LEMAITRE VASCULAR INC

For the period ended Jun 30, 2025. Filed Aug 6, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 6, 2025

LMAT$79.02-2.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Unregistered Sales of Equity Securities and Use of Proceeds

Recent Sales of Unregistered Securities

None.

Issuer Purchases of Equity Securities

	Issuer Purchases of Equity Securities
Maximum Number
(or Approximate
Total Number of · Dollar Value) of
Shares (or Units) · Shares (or Units)
Total · Average · Purchased as · that may yet be
Number of · Price · Part of Publicly · Purchased under
Shares (or Units) · Paid Per · Announced Plans · the Plans or
Period · Purchased (1) · Share (or Unit) · or Program · Program (2)
April 1, 2025 through April 30, 2025	33		$85.16	N/A	$75,000,000
May 1, 2025 through May 31, 2025	19		$80.26	N/A	$75,000,000
June 1, 2025 through June 30, 2025	-	$	-	N/A	$75,000,000
Total	52		$83.37	N/A

(1)	For the three months ended June 30, 2025, we repurchased 52 shares of our common stock to satisfy employees’ obligations with respect to minimum statutory withholding taxes in connection with the vesting of restricted stock units and performance-based restricted stock units.

(2)	On February 18, 2025, our Board of Directors authorized the repurchase of up to $75.0 million of our common stock through transactions on the open market, in privately negotiated transactions, or otherwise until February 17, 2026. To date, we have not made any repurchases under this program.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.